Healthpeak Properties (NYSE:DOC) Given Buy Rating at Argus
Argus restated their buy rating on shares of Healthpeak Properties (NYSE:DOC – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $25.00 target price on the real estate investment trust’s stock. Other research analysts also recently issued reports about the stock. Evercore ISI reduced their price objective on shares of […]
Argus restated their buy rating on shares of Healthpeak Properties (NYSE:DOC – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $25.00 target price on the real estate investment trust’s stock. Other research analysts also recently issued reports about the stock. Evercore ISI reduced their price objective on shares of […]
